×
About 86 results

ALLMedicine™ ACTH-secreting Pituitary Adenoma Center

Research & Reviews  43 results

Comprehensive Diagnosis and Surgical Management of Cushing Disease: Two-Dimensional Ang...
https://doi.org/10.1016/j.wneu.2021.01.036
World Neurosurgery; Body AM, Matur AV et. al.

Jan 23rd, 2021 - Cushing disease (CD), or hypercortisolemia secondary to an adrenocorticotropic hormone-secreting (ACTH-secreting) pituitary adenoma, is the most common etiology of noniatrogenic Cushing syndrome.1 The diagnostic algorithm employed in the patient w...

Nail hyperpigmentation in ACTH-secreting pituitary adenoma (Cushing's disease) and its ...
https://doi.org/10.1136/bcr-2020-234905
BMJ Case Reports; Sandoval MAS, Bruno RG

Apr 18th, 2020 - Nail hyperpigmentation in ACTH-secreting pituitary adenoma (Cushing's disease) and its resolution after successful trans-sphenoidal excision.|2020|Sandoval MAS,Bruno RG,|

Long-term follow-up for ectopic ACTH-secreting pituitary adenoma in a single tertiary m...
https://doi.org/10.1007/s11102-019-01017-y
Pituitary Zhu J, Lu L et. al.

Dec 15th, 2019 - Ectopic ACTH-secreting pituitary adenoma (EAPA) are a rare cause of Cushing's disease. Due to the lack of consensus and experience in terms of the diagnosis and treatment of EAPAs, preoperative identification and optimal treatment remain challengi...

Recovery of Adrenal Function after Pituitary Surgery in Patients with Cushing Disease: ...
https://doi.org/10.1159/000496846
Neuroendocrinology Serban AL, Sala E et. al.

Jan 13th, 2019 - Cushing disease (CD) represents the principal cause of endogenous hypercortisolism. The first-line therapy of CD is surgical removal of the ACTH-secreting pituitary adenoma, which is generally followed by adrenal insufficiency (AI). To analyze the...

Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456994
The Journal of Clinical Endocrinology and Metabolism; Lin AL, Jonsson P et. al.

Aug 7th, 2018 - Pituitary carcinoma is a rare and aggressive malignancy with a poor prognosis and few effective treatment options. A 35-year-old woman presented with an aggressive ACTH-secreting pituitary adenoma that initially responded to concurrent temozolomid...

see more →

Clinicaltrials.gov  43 results

Comprehensive Diagnosis and Surgical Management of Cushing Disease: Two-Dimensional Ang...
https://doi.org/10.1016/j.wneu.2021.01.036
World Neurosurgery; Body AM, Matur AV et. al.

Jan 23rd, 2021 - Cushing disease (CD), or hypercortisolemia secondary to an adrenocorticotropic hormone-secreting (ACTH-secreting) pituitary adenoma, is the most common etiology of noniatrogenic Cushing syndrome.1 The diagnostic algorithm employed in the patient w...

Nail hyperpigmentation in ACTH-secreting pituitary adenoma (Cushing's disease) and its ...
https://doi.org/10.1136/bcr-2020-234905
BMJ Case Reports; Sandoval MAS, Bruno RG

Apr 18th, 2020 - Nail hyperpigmentation in ACTH-secreting pituitary adenoma (Cushing's disease) and its resolution after successful trans-sphenoidal excision.|2020|Sandoval MAS,Bruno RG,|

Long-term follow-up for ectopic ACTH-secreting pituitary adenoma in a single tertiary m...
https://doi.org/10.1007/s11102-019-01017-y
Pituitary Zhu J, Lu L et. al.

Dec 15th, 2019 - Ectopic ACTH-secreting pituitary adenoma (EAPA) are a rare cause of Cushing's disease. Due to the lack of consensus and experience in terms of the diagnosis and treatment of EAPAs, preoperative identification and optimal treatment remain challengi...

Recovery of Adrenal Function after Pituitary Surgery in Patients with Cushing Disease: ...
https://doi.org/10.1159/000496846
Neuroendocrinology Serban AL, Sala E et. al.

Jan 13th, 2019 - Cushing disease (CD) represents the principal cause of endogenous hypercortisolism. The first-line therapy of CD is surgical removal of the ACTH-secreting pituitary adenoma, which is generally followed by adrenal insufficiency (AI). To analyze the...

Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456994
The Journal of Clinical Endocrinology and Metabolism; Lin AL, Jonsson P et. al.

Aug 7th, 2018 - Pituitary carcinoma is a rare and aggressive malignancy with a poor prognosis and few effective treatment options. A 35-year-old woman presented with an aggressive ACTH-secreting pituitary adenoma that initially responded to concurrent temozolomid...

see more →